Harrow Health Inc (HROW)
Healthcare
Drug Manufacturers - Specialty & Generic
39.10 $
+0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Harrow Health Inc (HROW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -9.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.6 | -1.2 | 8.7 | -4.6 | -2.7 | 3.0 | -18 | 20 | -0.8 | 17 | 8.4 | -9.0 | 15 | |
| 3.4 | 3.2 | 3.1 | 3.2 | 3.2 | 3.3 | 4.8 | 4.9 | 4.9 | 4.9 | 5.0 | 5.6 | 20 | |
| 5.4 | 4.5 | 4.2 | 4.2 | 4.3 | 4.4 | 4.8 | 4.6 | 0.9 | 3.3 | 3.8 | 3.8 | 12 | |
| 6.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.6 | -4.4 | 8.7 | -0.6 | -7.3 | -1.7 | -35 | 27 | -13 | -1.7 | -12 | 8.7 | -18 | |
| 1.2 | 20 | 0.2 | 0.1 | 0.3 | 0.6 | 38 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.9 | |
| -1.2 | -20 | -0.2 | -0.1 | 5.1 | -0.6 | -38 | -0.2 | -0.3 | -0.2 | -4.7 | -18 | -23 | |
| 0.2 | -12 | 0.0 | -1.2 | – | -1.2 | – | – | -13 | – | – | – | – | |
| – | – | – | – | – | 0.0 | 30 | 0.0 | – | – | 0.0 | 49 | – | |
| 0.2 | 64 | 0.0 | -0.8 | 0.1 | -0.7 | 30 | 0.0 | -13 | 5.0 | -5.0 | 49 | 36 | |
| 3.5 | 43 | 8.5 | -5.5 | 2.4 | 1.6 | -25 | 19 | -14 | 21 | -1.4 | 22 | 28 | |
| 3.3 | -21 | 8.5 | -4.7 | -3.1 | 2.3 | -55 | 19 | -1.0 | 16 | 8.1 | -9.2 | 14 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.